AUS
NZ
UK
CA
USA
IND
Healthcare
Clinuvel’s Drug Platform Update Gains ASX300 Focus
January 12, 2026 10:51 AM AEDT| By SamClinuvel’s latest update highlights progress in controlled-release drug delivery, showcasing in-house research strength and its growing role within healthcare innovation across the ASX three hundred landscape.
Sonic Healthcare (ASX:SHL) Shares Steady Amid ASX 50 Trading
January 09, 2026 06:02 PM AEDT| By SamThis article explores Sonic Healthcare Limited’s diagnostic healthcare services, operational structure, and placement within the ASX 50 market landscape.
Is Market Caution Masking Value in Australia’s Diagnostics Leader
January 09, 2026 12:26 PM AEDT| By SamMarket caution is prompting renewed evaluation of Australia’s diagnostics sector, highlighting the balance between defensive stability, innovation, and long-term healthcare relevance.
Australian Equity Coverage Across the S&P/ASX 200 and Broader Market Segments
January 08, 2026 05:45 PM AEDT| By SamA detailed overview of Australian companies operating across healthcare, resources, and infrastructure sectors within major S&P/ASX indices.
Ansell Executive Update Across ASX 200 and All Ordinaries Healthcare Segment
January 08, 2026 04:23 PM AEDT| By SamAnsell announces a new chief executive appointment, highlighting governance continuity, global operations, and its role across major Australian market indices.
Why Alcidion’s UK Health Win Is Turning Heads on the ASX
January 08, 2026 02:48 PM AEDT| By SamAlcidion’s UK hospital selection highlights Australia’s growing influence in digital healthcare, showcasing how specialised technology platforms can support global health system transformation.
ASX 200 Healthcare Stock Faces Leadership Shift as Market Reacts
January 08, 2026 12:28 PM AEDT| By SamA leadership change at a healthcare manufacturer sparks market reassessment, highlighting the importance of governance clarity and operational continuity.
Pro Medicus (ASX:PME) Shares Track ASX 300 After Earnings Growth
January 06, 2026 07:22 PM AEDT| By SamPro Medicus ASX 300 offers advanced medical imaging software, highlighting operational performance, technological integration, and healthcare sector alignment.
Discover Where Sonic Healthcare Stands On The ASX Today
January 06, 2026 05:55 PM AEDT| By SamA detailed exploration of Sonic Healthcare, its business landscape, and how healthcare stocks fit into the broader ASX environment, written in an easy, informative, SEO-friendly format.
Sonic Healthcare Coverage Across ASX 200 and Australian Healthcare Sector
January 06, 2026 05:26 PM AEDT| By SamSonic Healthcare operates within the healthcare diagnostics sector, delivering pathology and imaging services globally while maintaining inclusion across major Australian market indices.
Orthocell’s record revenue signals an expanding growth path
January 06, 2026 11:47 AM AEDT| By SamThis article explores how Orthocell (ASX:OCC) achieved record quarterly revenue, advanced international expansion, and strengthened commercial execution while building pathways across new healthcare markets.
Nanosonics (ASX:NAN) Shares Trade in Line With ASX 300 Index
January 05, 2026 09:35 PM AEDT| By SamNanosonics (ASX:NAN) provides automated infection control devices, emphasizing research and development, regulatory compliance, and operational deployment within the medical technology sector.
ASX 200 Today Small Cap Spotlight on Aroa Biosurgery and Sector Activity
January 05, 2026 06:10 PM AEDT| By SamHealthcare small-cap Aroa Biosurgery reflects sector diversification within the ASX landscape through medical technology operations and regulated product deployment.
Azer-cel Moves Imugene Forward in Next-Generation CAR-T Therapy
January 05, 2026 04:21 PM AEDT| By SamThis article explores how Imugene is advancing azer-cel, strengthening trial planning, expanding collaborations, and shaping new directions in CAR-T therapy while aligning with broader ASX healthcare and innovation themes.
CSL Shares: What Drove the Deep Slide and What It Means
January 05, 2026 12:31 PM AEDT| By SamThis article explores the wide-ranging factors that weighed on CSL shares, examining business fundamentals, division-level challenges, and broader market sentiment.
Actinogen’s ASX Move Signals Fresh Momentum for Local Biotech
January 02, 2026 04:40 PM AEDT| By Team Kalkine MediaActinogen Medical’s latest ASX disclosure highlights routine capital alignment, reinforcing transparency and governance within Australia’s biotech sector and offering context for readers following domestic equity developments.
Is ResMed CDI (ASX:RMD) Still Shaping Value For Investors?
December 31, 2025 08:23 PM AEDT| By SamResMed CDI explores opportunities through medical technology and digital care solutions while market participants assess value and long-term direction across healthcare and broader Australian equities.
Arovella moves IND toward first in human trial path
December 31, 2025 01:08 PM AEDT| By SamArovella Therapeutics (ASX:ALA) advances its IND submission for ALA-one-oh-one, outlining the pathway toward a first in human study for CD-nineteen-positive blood cancers and setting the groundwork for multi-region clinical activity.
Memphasys Share Quotation Update Signals Broader ASX Market Focus
December 31, 2025 11:44 AM AEDT| By SamMemphasys’ latest ASX share quotation highlights the importance of capital structure alignment, transparency, and steady market engagement within Australia’s evolving equity landscape.
Prescient Therapeutics Moves Forward Toward New Horizons Ahead
December 30, 2025 12:13 PM AEDT| By SamThe article explores how Prescient Therapeutics (ASX:PTX) advanced clinical development, strengthened regulatory positioning, and prepared for broader trial activity, setting the stage for the next phase of growth.
Advertise your brand on Kalkine Media